Company Filing History:
Years Active: 2009
Title: Innovator Spotlight: David Laurie
Introduction: David Laurie, an inventor based in Wylam, Great Britain, has made significant contributions to the field of vitamin D research. With a focus on enhancing the detection and measurement of vitamin D metabolites, his innovative methods have laid the groundwork for advancements in clinical diagnostics.
Latest Patents: David holds a patent for the "Determination of vitamin D metabolite and displacement from plasma or serum binding proteins." This patent discloses methods for measuring vitamin D metabolites in plasma or serum samples, which involve adding a non-competitive displacement agent. This agent, which includes 8-anilino-1-naphthalenesulfonic acid ammonium salt and 3-(acetonylbenzyl)-4-hydroxycoumarin in a water-miscible solvent, effectively separates vitamin D metabolites from the binding proteins in the samples. Hence, this invention is instrumental for capturing and detecting vitamin D metabolites that are otherwise tightly bound to serum or plasma binding proteins.
Career Highlights: David Laurie is associated with Immunodiagnostic Systems Limited, a company that specializes in diagnostic tools and innovations in healthcare. His role in bridging the gap between research and practical application has been pivotal in steering the company towards novel solutions in vitamin D measurement.
Collaborations: Throughout his career, David has worked alongside esteemed colleagues such as Alexander Kirkley Barnes and Michael James Gardner. Their collaborative efforts have been essential in advancing research protocol and methodologies in the realm of vitamin D diagnostics.
Conclusion: David Laurie's inventive approach to measuring vitamin D metabolites demonstrates his commitment to improving clinical diagnostics. His patent reflects a deep understanding of biochemistry and its application to health sciences, solidifying his place as a key innovator in this field. With his ongoing contributions, the future of vitamin D research and diagnostics continues to expand, promising better health outcomes through improved measurements.